StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.62−0.72 (-9.81%)

Close on Nov 17, 2026Market cap $399.15MP/E –Yield –

Eupraxia Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Eupraxia Pharmaceuticals's enterprise value was $336.47M on Nov 11, 2026, against $186.67M a year earlier. Over the last 4 years it ranged from $44.64M to $390.49M, with a median of $103.62M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$336.47M+43.5%
2025Dec 31, 2025$234.43M+256.2%
2024Dec 31, 2024$65.82M-7.3%
2023Dec 29, 2023$71.01M–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?